Buckley Mortimer J 4

What Happened
Mortimer J. Buckley, a member of Pfizer's Board of Directors, was granted 7,686.539 units (phantom shares) on 2026-04-23 at an assigned value of $26.67 per unit, totaling $205,000. This was an award/grant (transaction code A) under Pfizer’s non-employee director deferred compensation plan — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-23; grant value: $26.67 per unit; total value reported: $205,000.
• Units granted: 7,686.539 units representing phantom shares (derivative award).
• Shares/units owned after transaction: Not specified in the provided Form 4 data.
• Filing date: 2026-04-27 — filed within the standard Form 4 reporting window (timely).
• Transaction type/code: A = Award/Grant (derivative security).
• Footnotes from filing:
  • F1: Each unit represents one phantom share of common stock.
  • F2: Granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non‑Employee Directors.
  • F3: Units are deferred director compensation, settled in cash or common stock at the director’s election following retirement from the Board.

Context
These units are a form of deferred compensation (a derivative award) rather than immediate common stock ownership. They will be settled in cash or shares at the director’s election after he leaves the board, so the grant does not necessarily imply an immediate change in voting power or stock holdings. Such awards are common for non-employee directors and reflect compensation structure rather than an active buy or sell decision.